Biofrontera (BFRI) Free Cash Flow Growth (1y) (2021 - 2025)
Biofrontera (BFRI) Free Cash Flow Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 44.93% |
| 10 | Biofrontera | 10.78 Mn | 4.37 Mn | 14.09 Mn | -141.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.16% |
| Sep 30, 2025 | -201.51% |
| Jun 30, 2025 | 34.34% |
| Mar 31, 2025 | -22.73% |
| Dec 31, 2024 | 88.70% |
| Sep 30, 2024 | 38.15% |
| Jun 30, 2024 | 59.02% |
| Mar 31, 2024 | 9.61% |
| Dec 31, 2023 | -6.70% |
| Sep 30, 2023 | 65.69% |
| Jun 30, 2023 | -14,079.27% |
| Mar 31, 2023 | -76.44% |
| Dec 31, 2022 | 60.49% |
| Sep 30, 2022 | -396.56% |
| Jun 30, 2022 | 107.40% |
| Mar 31, 2022 | 38.09% |
| Dec 31, 2021 | -2,927.23% |